- List
- By Topic
- On Map
- Search Details
Study record managers: refer to the Data Element Definitions if submitting registration or results information.
x
1 | NCT00988364 | Unknown † | Effects of Ezetimibe, Simvastatin, and Vytorin on Reducing L5 a Subfraction of LDL in Patients With Metabolic Syndrome. |
|
|
Interventional | Phase 4 |
|
Other / Industry |
|
|
24 | All | 18 Years and older (Adult, Senior) | NCT00988364 | Merck-123 MK0653A |
October 2009 | April 2010 | July 2010 | October 2, 2009 | October 6, 2009 |
|